May lives another day, but Brexit hits another hurdle
A headline flashed across our Bloomberg screen at 2:10pm yesterday, it read........... Brussels – “there will be no negotiation on Brexit”..............
So there you have it, the UK and the EU cannot even resume negotiations because Brussels has spat the dummy.
It is a bit like a nasty divorce and just as the children suffer in that instance, so Britain will suffer because of the pig-headedness of the Brussels bureaucrats.
The British government managed to scrape through a no-confidence motion this morning, it was brought by the Labour Party yesterday following the Brexit vote. The government won the vote by 325 to 306 allowing them to proceed towards trying to do a deal before the exit on 29 March.
While the rest of the world is being tugged this way and that by elected - or in some cases unelected - representatives, it is nice to see scientists going about their work. The Geneva based particle research centre CERN has published its idea for a GBP20 billion successor to the Large Hadron Collider, which has been titled the Future Circular Collider.
Clearly there was no marketing committee at Cern and nor do they need one. The collider will be almost four times longer than the existing one and ten times more powerful. Scientists are interested to find an explanation for gravity and why galaxies are rotating faster than they should be, suggesting the universe is expanding faster than it should be.
Having mentioned Brussels earlier, it is worth drawing readers’ attention to news that Belgian national pétanque players have been accused by the Dutch of using cocaine to give themselves a performance enhancing edge. Apparently, Belgian players will sneak off to the toilet during a match and return wide-eyed and not put a boule wrong for the rest of the match.
With the exception of London, global markets were pretty steady yesterday and overnight leaving our market with an indicated futures gain of 9 points. The Aussie is a tad weaker at USD0.7186 and out long bond basis point weaker at 2.28%
Alex Moffat is a director at Joseph Palmer & Sons.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.